Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Use this LFCR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LFCR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LFCR SEC filings page. Lician reads the product cache first so this HTML stays unique to Lifecore Biomedical Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full LFCR income, balance, and cash tables.